Orthobond Awarded FDA De Novo Approval for Ostaguard Antibacterial Technology Today marks a major milestone for the Orthobond Corporation. More than 19 years in the making, Orthobond is awarded FDA De Novo Approval for our Ostaguard antibacterial surface treatment! This is the first ever granting by the FDA of a De Novo submission for a non-eluting coating designed to actively kill bacteria that contaminate the surface of a medical device. Today, is a major win for not only Orthobond, but the medical device industry and millions of patients worldwide who undergo medical device surgery.? Contact Orthobond today to give your medical device an antibacterial edge, with the Ostaguard surface treatment. https://lnkd.in/geKcZcVP
Orthobond Corporation
生物技术研究
Monmouth Junction,NJ 1,540 位关注者
Treating and Protecting the Surfaces of the World
关于我们
Orthobond is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces, with broad applications in the medical device industry and more such as commercial, industrial, automotive, and beyond. We’re the first company to utilize nanoscale surface modifications that can be permanently bound to any surface, killing bacteria, viruses, and fungi by mechanically rupturing pathogens without using antibiotics.
- 网站
-
https://www.orthobond.com
Orthobond Corporation的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Monmouth Junction,NJ
- 类型
- 私人持股
地点
-
主要
1 Deer Park STE A
US,NJ,Monmouth Junction,08852
Orthobond Corporation员工
动态
-
Last week’s LSI 2025 meeting didn’t disappoint! I enjoyed learning about the latest developments in #medtech as well as connecting with new service providers, potential partners and possible investors. I’d like to extend my thanks to the LSI team for giving me the opportunity to share the Orthobond Corporation antibacterial story.?Kudos to LSI for fostering a strong collaborative environment where companies can openly talk about their successes and challenges as entrepreneurial, forward-thinking businesses. The only way to harness the power of emerging technologies is to keep the conversation going. Together, we can create solutions for today’s most pressing medical concerns—and improve the quality of life for patients around the world. #LSIUSA2025 To learn more about Ostaguard? antibacterial surface technology, contact @Orthobond today.?https://lnkd.in/dr3hZ8x5
-
-
Orthobond Corporation CEO David Nichols presents on the topic of #innovation in #MedTech today at the LSI Conference! #LSIUSA25 #Ostaguard #Orthobond
-
-
A?letter?from our CEO: ? I look forward to the AAOS gathering every year.?It’s a wonderful opportunity to catch up with colleagues, learn about the innovations that are shaping the future of orthopedics and affirm our commitment to improving the quality of life for orthopedic patients around the world. ? Since Orthobond? introduced Ostaguard?, the AAOS meeting has taken on new meaning for the company. Now, I look forward to this chance to share our technology with the world—because it is truly a solution for the problem of bacterial contamination that we have all been waiting for.?We discussed applying the technology with many new partners at the meeting in the US and around the globe. ? I applaud all the pioneers who are working day in and day out to improve orthopedic outcomes for surgeons and patients alike. Together, we can touch millions of lives around the world. ? See you next year! David Nichols CEO, Orthobond To learn more about Ostaguard? antibacterial surface technology, contact Orthobond Corporation today.? https://lnkd.in/dr3hZ8x5
-
-
That’s a wrap on AAOS 2025!????From groundbreaking discussions to exciting innovations, this year’s conference delivered incredible insights. ???Top Takeaways: 1???Bacterial contamination was a hot topic, and the focus on this meeting’s President’s Symposium was “Orthopedic Infections: The Final Frontier” 2???Orthobond’s first partner Onkos saw a lot of interest in their?NanoCept??technology 3???We got a glimpse into the future with the innovations presented at the Shark Tank-like OrthoPitch event ? What resonated most with you at AAOS? Share your favorite takeaway in the comments! To learn more about Ostaguard? antibacterial surface technology, contact Orthobond Corporation today.? https://lnkd.in/dr3hZ8x5
-
We hope everyone attending #AAOS is having a great time so far!?Don't forget to stop by booth #2945 to meet our team and learn more about the latest advancements in contamination prevention. #AAOS2025 #Orthobond #Ostaguard #Biotech #medicaldevices #medtech #biotech #antibacterialcontamination
-
-
#AAOS2025?is here! We’re live in San Diego and, ready to talk all things?#orthopedic #biotech.????Come meet the?Orthobond Corporation?team at Booth #2945 and see how we’re advancing?#contamination #infection #prevention.? ? Drop by, say hi, and let’s shape the future of orthopedics together!
-
#AAOS2025 prep is underway in San Diego! ??? ?? Be sure to stop by Booth #2945 and say hi! ??
"There's very few meetings where you get a chance to see the orthopaedic community together." Are you ready? We are excited for YOU to experience the pinnacle of orthopaedic education at #AAOS2025! The Annual Meeting App is your go-to resource to plan your experience, connect with peers, and more. Download in your app store today to prepare for your week ahead!
-
The countdown to #AAOS2025 in San Diego is on! ? We’re excited to see the latest in orthopedic biotech take center stage—and share our own innovation, #Ostaguard at booth #2945 To learn more about Ostaguard? antibacterial surface technology, contact Orthobond Corporation today.? https://lnkd.in/dr3hZ8x5
此处无法显示此内容
在领英 APP 中访问此内容等
-
The future of Ostaguard?? Beyond improving the lives of individuals by minimizing device #contamination, #Ostaguard can help mitigate the global threat of drug-resistant #bacteria. #Orthobond?#Ostaguard?#Biotech?#medicaldevices?#medtech #biotech?#antibacterialcontamination To learn more about Ostaguard? #antibacterial surface #technology, contact Orthobond Corporation today. https://lnkd.in/grFHdkJG
-